Alberto Villanueva

21PUBLICATIONS
207CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption.

|May 27, 2026
Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.

|Jan 03, 2026
Tight junction-high and CDH17-positive cell population is the source of colorectal cancer liver metastases.

Daniel Alvarez-Villanueva, María Maqueda, Dina Harti

|Mar 21, 2025
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer.

Fernando Martín, Clara Alcon, Elba Marín

|Jan 09, 2025
Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Sara Ortega-Bertran, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz

|Aug 30, 2024
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.

Marie-Julie Nokin, Alessia Mira, Enrico Patrucco

Pageof 4

Frequent Collaborators

5 joint publications

August Vidal

4 joint publications

Maria Martínez-Iniesta

3 joint publications

Joan Montero

3 joint publications

Ernest Nadal